COMP <GO>
IRTC vs ABBV // NET PROFIT MARGIN
iRhythm Holdings Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: IRTC 4
— ABBV 9
▲ NET PROFIT MARGIN LEADER: ABBV
LAST: $123.37 (-3.47%) • MKT CAP: $4.21B
net-margins
-6.00%
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
net-margins
6.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRTC VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IRTC | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.60% | 70.20% | +0.40 | IRTC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.50% | 29.00% | -42.50 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.82% | 3.47% | -2.65 | ABBV | /fcf-yield <GO> |
| Operating Margin | -7.70% | 24.60% | -32.30 | ABBV | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -6.00% | 6.90% | -12.90 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 26.20% | 8.60% | +17.60 | IRTC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.01 | 5.33 | -2.32 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 7.40% | -0.60 | IRTC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.2 | 72.8 | -9.60 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 1.15 | -0.17 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.0x | 113.1x | -83.10 | IRTC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.21B | $513.86B | -$509.65B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IRTC REV | ABBV REV | IRTC GROSS % | ABBV GROSS % | IRTC FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $747.1M | $61.16B | 70.6% | 70.2% | $34.5M | $17.82B |
| FY 2024 | $591.8M | $56.33B | 68.9% | 70.0% | -$30.6M | $17.83B |
| FY 2023 | $492.7M | $54.32B | 44.0% | 44.0% | -$72.3M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRTC // BETA 0.98
ABBV // BETA 1.15